Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.
Berghauser Pont LM, Balvers RK, Kloezeman JJ, Nowicki MO, van den Bossche W, Kremer A, Wakimoto H, van den Hoogen BG, Leenstra S, Dirven CM, Chiocca EA, Lawler SE, Lamfers ML. Berghauser Pont LM, et al. Among authors: van den bossche w, van den hoogen bg. Gene Ther. 2015 Dec;22(12):947-59. doi: 10.1038/gt.2015.72. Epub 2015 Jul 21. Gene Ther. 2015. PMID: 26196249
Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy.
Buijs PR, van Amerongen G, van Nieuwkoop S, Bestebroer TM, van Run PR, Kuiken T, Fouchier RA, van Eijck CH, van den Hoogen BG. Buijs PR, et al. Among authors: van nieuwkoop s, van eijck ch, van amerongen g, van run pr, van den hoogen bg. Cancer Gene Ther. 2014 Nov;21(11):463-71. doi: 10.1038/cgt.2014.51. Epub 2014 Sep 26. Cancer Gene Ther. 2014. PMID: 25257305
Oncolytic viruses: From bench to bedside with a focus on safety.
Buijs PR, Verhagen JH, van Eijck CH, van den Hoogen BG. Buijs PR, et al. Among authors: van eijck ch, van den hoogen bg. Hum Vaccin Immunother. 2015;11(7):1573-84. doi: 10.1080/21645515.2015.1037058. Hum Vaccin Immunother. 2015. PMID: 25996182 Free PMC article. Review.
Armed oncolytic viruses: A kick-start for anti-tumor immunity.
de Graaf JF, de Vor L, Fouchier RAM, van den Hoogen BG. de Graaf JF, et al. Among authors: van den hoogen bg. Cytokine Growth Factor Rev. 2018 Jun;41:28-39. doi: 10.1016/j.cytogfr.2018.03.006. Epub 2018 Mar 19. Cytokine Growth Factor Rev. 2018. PMID: 29576283 Free PMC article. Review.
Developing oncolytic viruses for clinical use: A consortium approach.
Kemp V, Lamfers MLM, van der Pluijm G, van den Hoogen BG, Hoeben RC. Kemp V, et al. Among authors: van der pluijm g, van den hoogen bg. Cytokine Growth Factor Rev. 2020 Dec;56:133-140. doi: 10.1016/j.cytogfr.2020.06.010. Epub 2020 Jun 10. Cytokine Growth Factor Rev. 2020. PMID: 32553482 Free article. Review.
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment.
de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RWAL, Posthuma CC, van der Meer Y, Bárcena M, Haagmans BL, Snijder EJ, van den Hoogen BG. de Wilde AH, et al. Among authors: van nieuwkoop s, van der meer y, van den hoogen bg. J Gen Virol. 2013 Aug;94(Pt 8):1749-1760. doi: 10.1099/vir.0.052910-0. Epub 2013 Apr 25. J Gen Virol. 2013. PMID: 23620378 Free PMC article.
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
de Wilde AH, Jochmans D, Posthuma CC, Zevenhoven-Dobbe JC, van Nieuwkoop S, Bestebroer TM, van den Hoogen BG, Neyts J, Snijder EJ. de Wilde AH, et al. Among authors: van nieuwkoop s, van den hoogen bg. Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84. doi: 10.1128/AAC.03011-14. Epub 2014 May 19. Antimicrob Agents Chemother. 2014. PMID: 24841269 Free PMC article.
70 results